111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Down 78.6% in August

Key Points

• 111, Inc. Sponsored ADR (NASDAQ:YI) experienced a dramatic 78.6% decline in short interest in August, with short interest totaling just 900 shares as of August 31st.
• The company's most recent quarterly earnings reported a loss of ($0.20) EPS and revenue of $486.35 million, with a current stock price of $5.79.
• Institutional investors hold approximately 21.32% of the stock, with Connor Clark & Lunn Investment Management recently acquiring a new stake valued at about $92,000.

111, Inc. Sponsored ADR (NASDAQ:YI - Get Free Report) saw a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 900 shares, a decline of 78.6% from the August 15th total of 4,200 shares. Based on an average trading volume of 12,300 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 12,300 shares, the days-to-cover ratio is currently 0.1 days.

111 Price Performance

YI stock opened at $5.79 on Friday. The firm has a market capitalization of $50.03 million, a P/E ratio of -9.05 and a beta of 0.46. The business's 50-day moving average is $6.90 and its two-hundred day moving average is $7.70. 111 has a 1 year low of $4.14 and a 1 year high of $11.90.

111 (NASDAQ:YI - Get Free Report) last posted its quarterly earnings results on Thursday, June 19th. The company reported ($0.20) earnings per share (EPS) for the quarter. The business had revenue of $486.35 million during the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of 111 in a report on Saturday, August 30th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in 111 stock. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in 111, Inc. Sponsored ADR (NASDAQ:YI - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,338 shares of the company's stock, valued at approximately $92,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.13% of 111 at the end of the most recent reporting period. 21.32% of the stock is currently owned by institutional investors and hedge funds.

111 Company Profile

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.